CLINICAL CHARACTERISTICS OF OCULAR ADNEXAL MARGINAL ZONE NON HODGKIN LYMPHOMA

Anh Tú Đỗ, Thị Thu Hường Nguyễn, Huyền Nga Đỗ

Main Article Content

Abstract

Ocular adnexal marginal zone non Hodgkin lymphoma is a distinct and rare group of diseases. The study describes a series of cases conducted on 56 patients with marginal zone non-Hodgkin's lymphoma in ocular adnexa at the Department of Hematological oncology, K Hospital from March 2019 to June 2023, to evaluate some Clinical features of this distinct group of diseases. The results showed: average age 59.2 years old, majority of men (69.6%) and good performance status (PS= 0 (60.7%), PS=1 1 (35.7%)), reason Admission to the hospital was mainly due to palpable tumors (21.4%) and eye symptoms such as eyelid edema (19.6%), bulging eyes (19.6%), eye pain (16.1%), and the time of appearance is mainly less than 6 months (44.6%), the location of onset is mainly in the eye adnexa (71.4%); tumor location of the orbit (66.1%), eyelids (12.5%), lacrimal gland (12.5%), conjunctiva (8.9%); Most tumors were 2-4 cm in size (57.1%), stage I (48.2%), low risk (92.8%), Ki67 <5% (58.9%), the rate increases LDH and uric acid were low (1.8% and 8.9%, respectively).

Article Details

References

1. McKelvie PA, McNab A, Francis IC, Fox R, O’Day J. Ocular adnexal lymphoproliferative disease: a series of 73 cases. Clinical & Experimental Ophthalmology. 2001;29(6):387-393. doi:10.1046/j.1442-9071.2001.d01-18.x
2. Khalil MO, Morton LM, Devesa SS, et al. Incidence of marginal zone lymphoma in the United States, 2001-2009 with a focus on primary anatomic site. Br J Haematol. 2014;165(1):67-77. doi:10.1111/bjh.12730
3. Borie R, Wislez M, Thabut G, et al. Clinical characteristics and prognostic factors of pulmonary MALT lymphoma. European Respiratory Journal. 2009; 34(6): 1408-1416. doi: 10.1183/ 09031936.00039309
4. Demirci H, Shields CL, Karatza EC, Shields JA. Orbital lymphoproliferative tumors: analysis of clinical features and systemic involvement in 160 cases. Ophthalmology. 2008;115(9):1626-1631, 1631.e1-3. doi:10.1016/j.ophtha.2008.02.004
5. Rosado MF, Byrne GE, Ding F, et al. Ocular adnexal lymphoma: a clinicopathologic study of a large cohort of patients with no evidence for an association with Chlamydia psittaci. Blood. 2006; 107(2): 467-472. doi:10.1182/blood-2005-06-2332
6. Fernández CA, Henry RK, Shields CL, et al. Ocular adnexal lymphoma: A single-institution retrospective study. Saudi J Ophthalmol. 2021; 35(3): 230-238. doi: 10.4103/1319-4534. 343368
7. Ma WL, Yao M, Liao SL, et al. Chemotherapy alone is an alternative treatment in treating localized primary ocular adnexal lymphomas. Oncotarget. 2017; 8(46): 81329-81342. doi:10. 18632/oncotarget.18500
8. Zucca E, Conconi A, Martinelli G, et al. Final Results of the IELSG-19 Randomized Trial of Mucosa-Associated Lymphoid Tissue Lymphoma: Improved Event-Free and Progression-Free Survival With Rituximab Plus Chlorambucil Versus Either Chlorambucil or Rituximab Monotherapy. J Clin Oncol. 2017;35(17): 1905-1912. doi:10.1200/ JCO.2016.70.699